Theo Gulen

Publikationer
CV
Populärvetenskap och samverkan

Utvalda publikationer

Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2024;12(3):753-761
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders
Zaghmout T; Maclachlan L; Bedi N; Guelen T
Review: DIAGNOSTICS. 2023;13(24):3662
Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders
Beyens M; Toscano A; Ebo D; Guelen T; Sabato V
Article: IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. 2023;43(4):681-698
Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis
Gulen T
Review: DIAGNOSTICS. 2023;13(21):3307
A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
Gulen T
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2023;11(10):3010-3020
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Valent P; Hoermann G; Bonadonna P; Hartmann K; Sperr WR; Broesby-Olsen S; Brockow K; Niedoszytko M; Hermine O; Chantran Y; Butterfield JH; Greiner G; Carter MC; Sabato V; Radia DH; Siebenhaar F; Triggiani M; Guellen T; Alvarez-Twose I; Staudinger T; Traby L; Sotlar K; Reiter A; Horny H-P; Orfao A; Galli SJ; Schwartz LB; Lyons JJ; Gotlib J; Metcalfe DD; Arock M; Akin C
Article: DIAGNOSTICS. 2023;13(13):2241
Diagnostic Evaluation of Hypersensitivity Reactions to Antibiotics in a Large Cohort of Mastocytosis Patients
Jarkvist J; Gulen T
Article: BLOOD ADVANCES. 2023;7(9):1713-1724
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
Kennedy VE; Perkins C; Reiter A; Jawhar M; Luebke J; Kluin-Nelemans HC; Shomali W; Langford C; Abuel J; Hermine O; Niedoszytko M; Gorska A; Mital A; Bonadonna P; Zanotti R; Tanasi I; Mattsson M; Hagglund H; Triggiani M; Yavuz AS; Panse J; Christen D; Heizmann M; Shoumariyeh K; Mueller S; Elena C; Malcovati L; Fiorelli N; Wortmann F; Vucinic V; Brockow K; Fokoloros C; Papageorgiou SG; Breynaert C; Bullens D; Doubek M; Ilerhaus A; Angelova-Fischer I; Solomianyi O; Varkonyi J; Sabato V; Ruefer A; Schug TD; Hermans MAW; Fortina AB; Caroppo F; Bumbea H; Gulen T; Hartmann K; Elberink HO; Schwaab J; Arock M; Valent P; Sperr WR; Gotlib J
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2022;88(11):4845-4853
Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses
Kowalik A; de Monestrol I; Sorjonen K; Brockow K; Gulen T
Article: CANCERS. 2022;14(16):3942
Clinical Outcomes of Adults with Systemic Mastocytosis: A 15-Year Multidisciplinary Experience
Ungerstedt J; Ljung C; Klimkowska M; Gulen T
Review: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2022;10(8):1941-1950
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Valent P; Hartmann K; Bonadonna P; Gulen T; Brockow K; Alvarez-Twose I; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Butterfield JH; Lyons JJ; Sperr WR; Greiner G; Sotlar K; Kluin-Nelemans HC; Schwaab J; Lange M; George TI; Siebenhaar F; Broesby-Olsen S; Jawhar M; Nedoszytko B; Castells M; Orfao A; Gotlib J; Reiter A; Horny H-P; Triggiani M; Arock M; Metcalfe DD; Akin C
Article: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;77(8):2292-2312
Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper
Barbaud A; Garvey LH; Arcolaci A; Brockow K; Mori F; Mayorga C; Bonadonna P; Atanaskovic-Markovic M; Moral L; Zanoni G; Pagani M; Soria A; Jost M; Caubet J-C; Carmo A; Mona A-A; Alvarez-Perea A; Bavbek S; Benedetta B; Bilo MB; Blanca-Lopez N; Bogas HG; Buonomo A; Calogiuri G; Carli G; Cernadas J; Cortellini G; Celik G; Demir S; Dona I; Dursun AB; Eberlein B; Faria E; Fernandes B; Garcez T; Garcia-Nunez I; Gawlik R; Gelincik A; Gomes E; Gooi JHC; Grosber M; Gulen T; Hacard F; Hoarau C; Janson C; Johnston SL; Joerg L; Ozdemir SK; Klimek L; Kosnik M; Kowalski ML; Kuyucu S; Kvedariene V; Laguna JJ; Lombardo C; Marinho S; Merk H; Meucci E; Morisset M; Munoz-Cano R; Murzilli F; Nakonechna A; Popescu F-D; Porebski G; Radice A; Regateiro FS; Rockmann H; Romano A; Sargur R; Sastre J; Hofmeier KS; Sedlackova L; Sobotkova M; Terreehorst I; Treudler R; Walusiak-Skorupa J; Wedi B; Wohrl S; Zidarn M; Zuberbier T; Agache I; Torres MJ
Letter: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;77(6):1909-1911
Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
Lyberg K; Ekoff M; Westerberg CM; Engblom C; Dahlen B; Gulen T; Nilsson G
Letter: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2022;10(5):1377-1379
COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated
Lazarinis N; Bossios A; Gulen T
Article: IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. 2022;42(1):45-63
Anaphylaxis and Mast Cell Disorders
Gulen T; Akin C
Article: FRONTIERS IN ALLERGY. 2022;3:1071807
Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: A two-center retrospective cohort study
Bonadonna P; Olivieri F; Jarkvist J; Nalin F; Zanotti R; Maclachlan L; Gulen T
Review: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2021;9(11):3918-3928
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Gulen T; Akin C; Bonadonna P; Siebenhaar F; Broesby-Olsen S; Brockow K; Niedoszytko M; Nedoszytko B; Elberink HNGO; Butterfield JH; Sperr WR; Alvarez-Twose I; Horny H-P; Sotlar K; Schwaab J; Jawhar M; Zanotti R; Nilsson G; Lyons JJ; Carter MC; George TI; Hermine O; Gotlib J; Orfao A; Triggiani M; Reiter A; Hartmann K; Castells M; Arock M; Schwartz LB; Metcalfe DD; Valent P
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2021;148(3):889-894
Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis
Gulen T; Teufelberger A; Ekoff M; Westerberg CM; Lyberg K; Dahlen S-E; Dahlen B; Nilsson G
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2021;9(6):2139-2144
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Bonadonna P; Brockow K; Niedoszytko M; Elberink HO; Akin C; Nedoszytko B; Butterfield JH; Alvarez-Twose I; Sotlar K; Schwaab J; Jawhar M; Castells M; Sperr WR; Hermine O; Gotlib J; Zanotti R; Reiter A; Broesby-Olsen S; Bindslev-Jensen C; Schwartz LB; Horny H-P; Radia D; Triggiani M; Sabato V; Carter MC; Siebenhaar F; Orfao A; Grattan C; Metcalfe DD; Arock M; Gulen T; Hartmann K; Valent P
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2020;8(9):3093-3101
Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis
Jarkvist J; Brockow K; Gulen T
Article: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2020;75(1):169-177
Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection
Jarkvist J; Salehi C; Akin C; Gulen T
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2017;5(5):1248-1255
Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis
Gulen T; Ljung C; Nilsson G; Akin C
Review: CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. 2017;17(4):295-303
Pharmacotherapy of mast cell disorders
Guelen T; Akin C
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2017;47(7):909-917
Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis
Gulen T; Westerberg CM; Lyberg K; Ekoff M; Kolmert J; Bood J; Ohd J; James A; Dahlen S-E; Nilsson G; Dahlen B
Letter: LEUKEMIA. 2016;30(9):1953-1956
Detection of circulating mast cells in advanced systemic mastocytosis
Dahlin JS; Ungerstedt JS; Grootens J; Sander B; Guelen T; Haegglund H; Nilsson G
Review: JOURNAL OF INTERNAL MEDICINE. 2016;279(3):211-228
Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease
Gulen T; Hagglund H; Dahlen B; Nilsson G
Thesis / dissertation: 2014
Mast cell activation disorders : a liaison between anaphylaxis and mastocytosis
Gülen, Theo
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(9):1179-1187
The presence of mast cell clonality in patients with unexplained anaphylaxis
Gulen T; Hagglund H; Sander B; Dahlen B; Nilsson G
Editorial comment: THE LANCET. 2014;383(9928):1608
Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis
Gulen T; Hagglund H; Dahlen S-E; Sander B; Dahlen B; Nilsson G
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(1):121-129
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience
Gulen T; Hagglund H; Dahlen B; Nilsson G
Article: TRANSFUSION. 1999;39(6):593-598
FcγRIIIB polymorphism:: evidence that NA1/NA2 and SH are located in two closely linked loci and that the SH allele is linked to the NA1 allele in the Danish population
Steffensen R; Gülen T; Varming K; Jersild C
Visa fler

Artiklar

Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2024;12(7):1850-1862.e1
Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts
Beyens M; Sabato V; Ebo DG; Zaghmout T; Gulen T
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2023;11(6):1706-1717
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives
Valent P; Hartmann K; Bonadonna P; Sperr W; Niedoszytko M; Kluin-Nelemans HC; Hermine O; Sotlar K; Hoermann G; Nedoszytko B; Broesby-Olsen S; Zanotti R; Lange M; Doubek M; Brockow K; Alvarez-Twose I; Varkonyi J; Yavuz S; Nilsson G; Radia D; Grattan C; Schwaab J; Gillen T; Elberink HNGO; Haegglund H; Siebenhaar F; Hadzijusufovic E; Sabato V; Mayer J; Reiter A; Orfao A; Horny H-P; Triggiani M; Arock M
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2022;21:s108
P153 Hypersensitivity reactions to antibiotics in patients with cystic fibrosis
Kowalik A; de Monestrol I; Sorjonen K; Gülen T
Article: ACTA DERMATO-VENEREOLOGICA. 2016;96(5):602-612
Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus
Broesby-Olsen S; Dybedal I; Gulen T; Kristensen TK; Moller MB; Ackermann L; Saaf M; Karlsson M; Agertoft L; Brixen K; Hermann P; Stylianou E; Mortz CG; Torfing T; Havelund T; Sander B; Bergstrom A; Bendix M; Garvey LH; Weis Bjerrum O; Valent P; Bindslev-Jensen C; Nilsson G; Vestergaard H; Hagglund H
Article: ACTA DERMATO-VENEREOLOGICA. 2014;94(5):583-584
Increased Risk of Malignant Melanoma in Patients with Systemic Mastocytosis?
Hagglund H; Sander B; Gulen T; Lindelof B; Nilsson G
Article: MEDICAL ONCOLOGY. 2014;31(8):123
Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis
Hagglund H; Sander B; Ahmadi A; Gulen T; Nilsson G
Article: CLINICAL AND TRANSLATIONAL ALLERGY. 2013;3(1):22
The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.
Gülen T; Dahlén B; Sander B; Hägglund H; Nilsson G
Article: MEDICAL ONCOLOGY. 2012;29(5):3540-3546
Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm
Gulen T; Sander B; Nilsson G; Palmblad J; Sotlar K; Horny H-P; Hagglund H
Article: LAKARTIDNINGEN. 2007;104(24-25):1881-1882
[Take advantage of the foreign physicians' experiences].
Shemais H; Hot-Bjelak A; Pavlakovic ST; Gülen T

Alla övriga publikationer

Review: CURRENT ALLERGY AND ASTHMA REPORTS. 2024;24(2):39-51
Using the Right Criteria for MCAS
Gulen T
Review: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2022;10(8):2015-2024
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Pyatilova P; Akin C; Alvarez-Twose I; Arock M; Bonadonna P; Brockow K; Butterfield JH; Broesby-Olsen S; Carter MC; Castells M; George TI; Gotlib J; Greiner G; Gulen T; Hartmann K; Hermine O; Horny H-P; Jawhar M; Lange M; Lyons JJ; Maurer M; Metcalfe DD; Nedoszytko B; Niedoszytko M; Orfao A; Reiter A; Schwaab J; Sotlar K; Sperr WR; Triggiani M; Valent P; Siebenhaar F
Letter: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2022;10(4):1128
Reply to "Need to define a subgroup of patients with idiopathic mast cell activation syndrome"
Gulen T; Akin C; Metcalfe DD; Valent P
Preprint: AUTHOREA PREPRINTS. 2021
Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
Nilsson G; Lyberg K; Ekoff M; Westerberg CM; Engblom C; Dahlen B; Gulen T
Review: CURRENT ALLERGY AND ASTHMA REPORTS. 2021;21(2):11
Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists
Gulen T; Akin C
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(3):1454
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
Romantowski J; Gorska A; Niedoszytko M; Gulen T; Gruchala-Niedoszytko M; Nedoszytko B; Lange M; Brockow K; Arock M; Akin C; Valent P
Book chapter: MASTOCYTOSIS. 2020;p. 141-155
Anaphylaxis in Mastocytosis
Gülen T; Oude Elberink JNG; Brockow K
Editorial comment: ACTA DERMATO-VENEREOLOGICA. 2018;98(1):149-150
Pre-emptive Evaluation of Venom Allergy in a Patient with Systemic Mastocytosis
Guelen T; Akin C
Conference publication: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2017;72:445
Altered mast cell reactivity in patients with mastocytosis
Gulen T; Lyberg K; Westerberg MC; Ekoff M; Alexeyenko A; Dahlen B; Nilsson G
Review: LAKARTIDNINGEN. 2016;113:D7CI
[Insect venom allergy – the diagnosis can be difficult to make but good treatment is available].
Gülen T; Björkander J
Review: LAKARTIDNINGEN. 2016;113:DTED
[Anaphylaxis can be life-threatening, treatment must be initiated promptly].
Gülen T; Wickman M
Editorial comment: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(9):1099
The Editor takes a closer look at some of this month's articles
Zhang X-Y; Ziyab A; Guelen T
Review: LAKARTIDNINGEN. 2012;109(9-10):474-477
[Systemic mastocytosis. Underestimated condition in patients with idiopathic anaphylaxis].
Gülen T; Gottberg L; Dahlén B; Nilsson G; Hägglund H
Review: LAKARTIDNINGEN. 2008;105(46):3341-3347
[Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital].
Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G
Review: LAKARTIDNINGEN. 2007;104(26-27):1982-1986
[Anaphylaxis--a potentially life-threatening systemic reaction. Immediate and adequate emergency treatment is of significance].
Gülen T; Gottberg L

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2024-2027
Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, Allergologi, Karolinska Institutet, 2023
Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2014

Utvalda publikationer

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI